Clinical Trials Browser

Phase 3 × Lymphoma, Non-Hodgkin × Vinorelbine × Clear all

NCT00088530 2020-02-05

BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL)

Phase 3 Completed

140 enrolled 15 charts

Lymphoma, Non-Hodgkin